Abstract: Since skin condition is significantly influenced by environmental factors associated with lifestyle habits, it has been difficult to forecast skin condition by means of SNP analysis. The purpose of the present invention is to determine one's congenital skin characteristics, which has been difficult with the prior art. The present invention provides a method for determining not only one's congenital skin characteristics but also future skin type by determining skin condition from genetic and environmental factors.

Abstract: Provided are a counseling method and counseling device which present a skincare advice appropriate to a user. The counseling device includes an obtaining unit that obtains genetic information representing a result of a genetic test on a user and stratum corneum information representing a result of a stratum corneum test on the user; a skin constitution determining unit that determines skin constitution of the user, based on the genetic information; a skin capability determining unit that determines skin capability representing a skin condition of the user, based on the stratum corneum information; an identifying unit that identifies a skincare advice and/or a cosmetic to be proposed to the user, based on the skin constitution and the skin capability; and a presenting unit that presents counseling information including information on the skincare advice and/or cosmetic to the user.

Abstract: It is an object of the present invention to find substances that can be used as skin aging markers, and the present invention provides a method for determining the degree of skin aging, including measurement of expression of secretory proteins and/or intracellular proteins and/or their genes in skin cells and/or skin tissues, wherein the secretory proteins and/or intracellular proteins change their expression with aging of skin. The present invention also provides a kit for determining the degree of skin aging and a method for identifying substances effective in the prevention of skin aging.

Abstract: It is an object of the present invention to find substances that can be used as disease markers for atopic dermatitis and the present invention provides a method for determining atopic dermatitis, including measurement of the expression of specific proteins and/or their genes in skin cells and/or skin tissues, wherein the specific proteins change their expression with inflammation caused by atopic dermatitis or change their expression according to the degree of predisposition to atopic dermatitis. The present invention also provides a kit for determining the degree of inflammation of atopic dermatitis or risk of developing atopic dermatitis, as well as a method for determining substances effective in the treatment and/or prevention of atopic dermatitis.

Abstract: It is an object of the present invention to find substances that can be used as skin aging markers, and the present invention provides a method for determining the degree of skin aging, including measurement of expression of secretory proteins and/or intracellular proteins and/or their genes in skin cells and/or skin tissues, wherein the secretory proteins and/or intracellular proteins change their expression with aging of skin. The present invention also provides a kit for determining the degree of skin aging and a method for identifying substances effective in the prevention of skin aging.

Abstract: It is an object of the present invention to find substances that can be used as disease markers for atopic dermatitis and the present invention provides a method for determining atopic dermatitis, including measurement of the expression of specific proteins and/or their genes in skin cells and/or skin tissues, wherein the specific proteins change their expression with inflammation caused by atopic dermatitis or change their expression according to the degree of predisposition to atopic dermatitis. The present invention also provides a kit for determining the degree of inflammation of atopic dermatitis or risk of developing atopic dermatitis, as well as a method for determining substances effective in the treatment and/or prevention of atopic dermatitis.